Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D8CJE9
|
|||
| Drug Name |
Norketotifen
|
|||
| Synonyms |
Nor-ketotifen; 34580-20-6; UNII-Z24BD2IFB3; Z24BD2IFB3; 2-piperidin-4-ylidene-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one; GNF-Pf-187; N-Desmethylketotifen; Oprea1_655550; SCHEMBL936577; CHEMBL1197564; BDBM181150; ZINC5517457; 4-(piperidin-4-ylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one; AKOS005067756; AS-73103; US9138431, R-NORKETOTIFEN (RNORK); US9138431, RS-NORKETOTIFEN (NORK); 10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(4-piperidinylidene)-; 4,9-Dihydro-4-(4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one; 2-(PIPERIDIN-4-YLIDENE)-6-THIATRICYCLO[8.4.0.0(3),?]TETRADECA-1(14),3(7),4,10,12-PENTAEN-8-ONE
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 2 | [1] | |
| Company |
Emergo Therapeutics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H17NOS
|
|||
| Canonical SMILES |
C1CNCCC1=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3
|
|||
| InChI |
1S/C18H17NOS/c20-16-11-13-3-1-2-4-14(13)17(12-5-8-19-9-6-12)15-7-10-21-18(15)16/h1-4,7,10,19H,5-6,8-9,11H2
|
|||
| InChIKey |
IYSYPCSSDZBWHN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 34580-20-6
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04043923) Norketotifen for the Treatment of Uncomplicated Influenza-like Illness. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.